Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
about
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationHepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcomeΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationManagement of patients with hepatitis B in special populationsClinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxisPrevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesSpontaneous resolution of de novo hepatitis B after living donor liver transplantation with hepatitis B core antibody positive graft: a case report.Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.Recent advances in prevention of hepatitis B recurrence after liver transplantation.Antiviral treatment for hepatitis B virus recurrence following liver transplantation.Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis.A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant.Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report.Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.Current treatment indications and strategies in chronic hepatitis B virus infection.Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
P2860
Q26784241-759A9801-4B4C-4E76-A643-58582D2E3206Q26859121-80D93A2B-640B-482A-95A0-F6C36BA216E1Q26864647-24DF89F3-34EF-4C24-8C31-DFE6C81B4657Q27016136-C956E0D8-925B-4E2A-9471-592AB13B856DQ34029115-EDA829A8-605C-4AD2-A8D9-224514AED09FQ35549423-641D211B-6799-4FF7-9C5A-4D4F2A4CD3E0Q36442537-03668EBD-0E95-4671-936B-97A1E4869082Q37372998-24FD0743-BFFD-4936-B960-A0A922ABB098Q37468277-7D86162E-4ECB-48BD-A1E0-E747073E1CBDQ37870833-9A9453AA-7209-4DD5-B124-62370DA6AA9AQ37886893-95BCF57B-37B1-4B32-B734-46F96CFFD0C3Q38006958-EECCF567-A4BE-4A20-88E9-E4EA37EC6E78Q38058545-3B939B28-E332-4896-86C6-5097D7A20480Q38177252-BDE69CD4-28B9-4835-8C4A-4B2B5B42488FQ38333875-255A55BE-D6D6-49F5-B5E4-CE33F36C7D56Q38446412-DBC5F96B-B0B6-4914-926F-241C3E289E61Q38665203-95602DA4-D5FB-4A19-B172-CEAACBCAE132Q40588229-971F9321-A555-4D37-B012-0D243B4F07C9Q41120439-977F8412-78EF-4DAE-AF9B-5E841465FB79Q41468537-7561A4DF-44CF-4775-8CB7-0767B1F43719Q42204862-4392C525-1E3D-41D8-BC82-9ECA7C90CD57Q42439836-CAA6919F-89A0-4DFA-9F90-47EEACA0F2F9Q42619923-902EE3CF-4439-4FFA-9CAC-7D627EBA1056Q44217548-5D8703ED-2E22-4EF7-B45A-7C92DFFE5D1EQ45399119-6418327F-56AF-4E74-9788-042D4330B5D8
P2860
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prevention of and treatment fo ...... the nucleoside analogues era.
@ast
Prevention of and treatment fo ...... the nucleoside analogues era.
@en
type
label
Prevention of and treatment fo ...... the nucleoside analogues era.
@ast
Prevention of and treatment fo ...... the nucleoside analogues era.
@en
prefLabel
Prevention of and treatment fo ...... the nucleoside analogues era.
@ast
Prevention of and treatment fo ...... the nucleoside analogues era.
@en
P2860
P1476
Prevention of and treatment fo ...... the nucleoside analogues era.
@en
P2093
George V Papatheodoridis
Vasilios Sevastianos
P2860
P304
P356
10.1034/J.1600-6143.2003.00063.X
P407
P577
2003-03-01T00:00:00Z